Professor of Medicine, Temple University
Hematology
Dr. Thomas R. Klumpp, MD
Thomas Klumpp practices Hematology. He researched medicine at Perelman School of Medicine at the University of Pennsylvania. He received awards:"Regional Top Doctor" and "Super Doctor". Thomas Klumpp is a published MD. He has 65 papers published. The most current publication "Value of the pretransplant evaluation in predicting toxic day-100 mortality among blood stem-cell and bone marrow transplant recipients." He accepts Medicare.
Publications
- Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies.
- Increasing incidence of Chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.
- Older Patients with Myeloma Derive Similar Benefit from Autologous Transplantation.
- Electronic medical records and quality of cancer care.
- Providing Personalized Prognostic Information for Adult Leukemia Survivors.
- Outcome of Lower-Intensity Allogeneic Transplantation in Non-Hodgkin Lymphoma after Autologous Transplantation Failure.
- Risk factors associated with increased non-relapse mortality and with poor overall survival in children with Chronic graft-versus-host disease.
- Classifying Cytogenetics in Patients with AML in Complete Remission Undergoing Allogeneic Transplantation: A CIBMTR Study.
- Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis.
- The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acu...
- A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell Lymphoma: a report from the CIBMTR.
- Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-...
- A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation.
- Unrelated donor transplants in adults with Philadelphia-negative Acute lymphoblastic leukemia in first complete remission.
- Lack of effect of donor-recipient Rh mismatch on outcomes after allogeneic hematopoietic stem cell transplantation.
- Mixed chimerism and Graft failure following conditioning with the fludarabine and cyclophosphamide nonablative regimen; conversion to full donor chimerism.
- R-CHOP for mantle cell Lymphoma.
- Use of ibritumomab tiuxetan anti-CD20 radioimmunotherapy in a non-Hodgkin's Lymphoma patient previously treated with a yttrium-90-labeled anti-CD22 monoclonal antibody.
- Single-donor platelets reduce the risk of septic platelet transfusion reactions.
- [Plasma variations in severe head injuries: prognosis and post-traumatic surveillance. I. Enzymes].
- Autoimmune Pancytopenia following bone marrow transplantation.
- Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for Acute myeloid leukemia in first remission with unfavorable cytogeneti...
- Severe cutaneous ulceration following treatment with thalidomide for GVHD.
- Mobilization of peripheral blood stem cells by subcutaneous injections of yeast-derived granulocyte macrophage colony stimulating factor: a phase I-II study.
- Measurable immune dysfunction and telomere attrition in long-term allogeneic transplant recipients.
- Economic consequences of alterations in platelet transfusion dose: analysis of a prospective, randomized, double-blind trial.
- Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trial.
- Value of the pretransplant evaluation in predicting toxic day-100 mortality among blood stem-cell and bone marrow transplant recipients.
- The erythroid Leukemias: a comparative study of erythroLeukemia (FAB M6) and Di Guglielmo disease.
- Phase II study of high-dose cyclophosphamide, etoposide, and carboplatin (CEC) followed by autologous hematopoietic stem cell rescue in women with metastatic or high-r...
- Effect of hematopoietic growth factors on the rate of neutrophil recovery following peripheral blood stem cell transplantation.
- Detection of a dormant 20q- Leukemia clone in bone marrow cultures with hematopoietic growth factors: implications for secondary Leukemia post-transplant.
- Treatment of hepatic veno-occlusive Disease with low-dose tissue plasminogen activator: impact on coagulation profile.
- Association between antibodies reactive with neutrophils, rate of neutrophil enGraftment, and incidence of post-enGraftment neutropenia following BMT.
- Factors associated with response to platelet transfusion following hematopoietic stem cell transplantation.
- Antibody-mediated Neutropenia following bone marrow transplantation.
- Graft failure following neutrophil-specific alloantigen mismatched allogeneic BMT.
- Autoimmune Neutropenia after bone marrow transplantation.
- The effect of minor ABO mismatches on the incidence of Graft-versus-host disease after allogeneic bone marrow transplantation.
- Phase II pilot study of high-dose busulfan and CY followed by autologous BM or peripheral blood stem cell transplantation in patients with advanced chemosensitive brea...
- Refractory thrombocytopenia in a 27-year-old female following allogeneic bone marrow transplantation.
- Lack of transmission of neutrophil and platelet antibodies by intraVenous immunoglobulin in bone marrow transplant patients.
- Lack of a graft-versus-Leukemia effect in an immunologically privileged sanctuary site.
- Complications of peripheral blood stem cell transplantation.
- Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2.
- Complications of peripheral blood stem cell harvesting: review of 554 PBSC leukaphereses.
- Autoimmune thrombocytopenia after autologous bone marrow transplantation.
- Effect of granulocyte colony-stimulating factor on the rate of neutrophil enGraftment following peripheral-blood stem-cell transplantation.
- Granulocyte colony-stimulating factor accelerates neutrophil enGraftment following peripheral-blood stem-cell transplantation: a prospective, randomized trial.
- A retrospective comparison of three different methods for mobilization of peripheral blood stem cells.
- Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients wi...
- Malignant myoepithelioma of the parotid gland: case report and review of the literature.
- Autoimmune Pancytopenia following allogeneic bone marrow transplantation.
- Extended continuous infusion low-dose recombinant interleukin-2 in advanced cancer: prolonged immunomodulation without significant toxicity.
- Immunohematologic complications of bone marrow transplantation.
- Fracture of the ilium: an unusual complication of bone marrow harvesting.
- Autoimmune Neutropenia following peripheral blood stem cell transplantation.
- Immune-mediated cytopenia following bone marrow transplantation. Case reports and review of the literature.
- Economic analysis of conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast ...
- Serum protein electrophoresis abnormalities in adult solid organ transplant patients with post-transplant lymphoproliferative disorder.
- Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for Lymphoma: a report o...
- Hematopoietic reconstitution by transplantation of stem cells from bone marrow or blood.
- Lack of effect of donor-recipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantation.
- ABO blood group barrier in allogeneic bone marrow transplantation revisited.
Schools
Perelman School of Medicine University of Pennsylvania
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Chronic Myeloid Leukemia (CML)
- Graft vs Host Disease
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Regional Top Doctor
- Super Doctor
Education
-
Massachusetts General Hospital -
Dartmouth-Hitchcock Medical Center -
Perelman School of Medicine at the University of Pennsylvania
Hospital
-
Fox Chase Cancer Center-American Oncologic Hospital -
Temple University Hospital -
Thomas Jefferson University Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1194713271 |
| Last Name Of The Provider | KLUMPP |
| First Name Of The Provider | THOMAS |
| View All |
Similar Doctors
|
Dr. Alex W. Chu, MD |
|
|
Dr. Apurv Agrawal, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory M. Lubiniecki, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abdul M. Adjei, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Meghna S. Trivedi, MD |
|
|
Dr. Claire F. Friedman, MD |
|
|
Dr. Rene R. Rubin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert C. Young, MD |
|
|
Dr. Essel D. Al-Saleem, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Douglass A. Drelich, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark Y. Chiang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alison Rager, MD |
|
|
Dr. Steven H. Stein, MD |
|
|
Dr. Du Pont Guerry IV, MD |
|
|
Dr. Stephen Emerson, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Alan L. Friedman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John A. Kosteva, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Margaret T. Kasner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elaine Y. Chiang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roger B. Cohen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christian M. Squillante, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roy N. Gay, MD
This Doctor is OpenDoctor Recommended.
|